Poly Medicure Appoints Indranil Mukherjee as CEO for India and Asia Pacific

Poly Medicure Limited announced the appointment of Mr. Indranil Mukherjee as the Chief Executive Officer (CEO) for its Asia Pacific and India business. This strategic appointment is effective from June 01, 2026, and Mr. Mukherjee will report directly to the Managing Director as a Senior Management Personnel (SMP).

What just happened

The company has created a new leadership role, appointing a dedicated CEO for the crucial India and Asia Pacific regions. This move aims to strengthen operational focus and leadership.

Why this matters

This appointment signifies Poly Medicure's strategic intent to accelerate growth and enhance its competitive position in the high-growth Asia Pacific and Indian markets. Experienced leadership is expected to drive market expansion and operational efficiency.

The backstory

Mr. Mukherjee is a seasoned executive with over three decades of experience in the medical technology sector. His previous roles include Managing Director for B. Braun Group in India, Global Sales Manager for B. Braun in Germany, and Regional Head for Hospital Care at B. Braun's Asia Pacific headquarters. He also served as Group Chief Executive Officer at Translumina Therapeutics.

What changes now

With this appointment, Poly Medicure aims to leverage Mr. Mukherjee's expertise in scaling businesses, M&A integration, and strategy execution to drive performance in the Asia Pacific and India markets. His deep understanding of medical consumables, infusion products, capital equipment, and implants will be key.

Risks to watch

Investors will be keen to see how Mr. Mukherjee implements his strategies and integrates into the company's existing structure. Success will depend on his ability to navigate the competitive landscape and achieve growth targets.

Peer comparison

While specific peer appointments are not detailed in the filing, the trend of appointing regional CEOs with extensive industry experience is common among large medical device companies seeking to bolster their presence in rapidly expanding markets like India and Southeast Asia.

Context metrics (time-bound)

The appointment is effective June 01, 2026, providing a clear future roadmap for leadership transition.

What to track next

Investors should monitor future management commentary for specific strategic initiatives, growth plans, and potential M&A activities related to the Asia Pacific and India business under Mr. Mukherjee's leadership.